Two Sigma Advisers’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $488K | Buy |
+70,200
| New | +$488K | ﹤0.01% | 1762 |
|
2024
Q4 | – | Sell |
-11,300
| Closed | -$256K | – | 2348 |
|
2024
Q3 | $256K | Sell |
11,300
-19,600
| -63% | -$444K | ﹤0.01% | 1977 |
|
2024
Q2 | $625K | Sell |
30,900
-15,700
| -34% | -$318K | ﹤0.01% | 1788 |
|
2024
Q1 | $1.16M | Sell |
46,600
-15,607
| -25% | -$389K | ﹤0.01% | 1509 |
|
2023
Q4 | $1.12M | Sell |
62,207
-8,493
| -12% | -$154K | ﹤0.01% | 1588 |
|
2023
Q3 | $1.42M | Sell |
70,700
-68,700
| -49% | -$1.38M | ﹤0.01% | 1373 |
|
2023
Q2 | $3.56M | Sell |
139,400
-48,500
| -26% | -$1.24M | 0.01% | 916 |
|
2023
Q1 | $4M | Buy |
187,900
+26,100
| +16% | +$555K | 0.01% | 905 |
|
2022
Q4 | $4.79M | Sell |
161,800
-100,900
| -38% | -$2.99M | 0.01% | 802 |
|
2022
Q3 | $6.11M | Sell |
262,700
-152,500
| -37% | -$3.55M | 0.02% | 658 |
|
2022
Q2 | $6.97M | Buy |
415,200
+286,400
| +222% | +$4.81M | 0.02% | 631 |
|
2022
Q1 | $5.65M | Buy |
128,800
+31,600
| +33% | +$1.39M | 0.02% | 752 |
|
2021
Q4 | $5.92M | Buy |
97,200
+50,500
| +108% | +$3.07M | 0.01% | 694 |
|
2021
Q3 | $1.94M | Buy |
+46,700
| New | +$1.94M | 0.01% | 1274 |
|